Anorexia: a taste of things to come?

Abstract

Get full access to this article

View all access options for this article.

References

Pirovano M , Maltoni M , Nanni O , et al. A new palliative care score: a first step for the staging of terminally ill cancer patients. Italian multicenter study group on palliative care . J Pain Symptom Manage 1999; 17: 231-239 .

Laviano A , Meguid MM , Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies . Lancet Oncol 2003; 4: 686-694 .

Markinson S , Foster AC , Chen C , et al. The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule mealnocortin-4 receptor antagonist . Endocrinology 2005; 146: 2766-2773 .

Schwartz MW , Woods SC , Porte D Jr , et al. Central nervous system control of food intake . Nature 2000; 404: 661-671 .

Ramos EJB , Meguid MM , Campos ACL , Coelho JCU. Neuropeptide Y, a-melanocyte stimulating hormone, and monoamines in food intake regulation . Nutrition 2005; 21: 269-279 .

Laviano A , Meguid MM , Inui A , Muscaritoli M , Rossi-Fanelli F. Therapy insight - when all you can eat is yourself . Nature Clin Pract Oncol 2005; 2: 158-165 .

Ramos EJB , Suzuki S , Marks D , et al. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides . Curr Opin Clin Nutr Metab Care 2004; 7: 427-434 .

Davis MP , Dreicer R , Walsh D , Langman R , LeGrand SB. Appetite and cancer-associated anorexia: a review . J Clin Oncol 2004; 22: 1510-1517 .

Makarenko IG , Meguid MM , Gatto L , et al. Normalisation of hypothalamic serotonin (5-HT1B) receptor and NPY in cancer anorexia after tumour resection: an immunocytochemical study . Neurosci Lett 2005; 383: 322-327 .

10.

Marks DL , Ling N , Cone RD. Role of central melanocortin system in cachexia . Cancer Res 2001; 61: 1432-1438 .

11.

Cheung W , Yu PX , Little BM , et al. Role of leptin and melanocortin signaling in uremia-associated cachexia . J Clin Invest 2005; 115: 1659-1665 .

12.

Vos TJ , Caracoti A , Che JL , et al. Identification of 2-[2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl]- 4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumour-induced weight loss in a mouse model . J Med Chem 2004; 47: 1602-1604 .

13.

Marks D. Personal communication, 2005.